Joint Efforts Towards the Future of Wearable Neuroprosthetics
March 14, 2017 | EPFLEstimated reading time: 3 minutes
EPFL scientists Stéphanie Lacour and Grégoire Courtine report on the status of their research and share their vision about the future of wearable neuroprosthetics at this year’s edition of South by South West in Austin, Texas, on March 12th. Courtine shares some preliminary impressions about clinical trials addressing paralysis that are currently underway at the Lausanne University Hospital.
Scientists Stéphanie Lacour and Grégoire Courtine of Ecole polytechnique fédérale de Lausanne (EPFL) in Switzerland are paving the way for new, intelligent neuroprosthetics that may one day assist people with neurological dysfunction in everyday tasks. Neuroprosthetic devices are electronics that communicate with the nervous system, and the scientists are working together to translate their findings from the lab to the clinic.
Clinical trials currently underway
In the lab, Grégoire Courtine recently showed that paralyzed primates could walk again with the assistance of a smart neuroprosthetic system he calls the “brain-spine interface”. This wireless – fully wearable – neuroprosthetic interface essentially decodes brain signals about walking and stimulates the spinal cord to contract the correct group of leg muscles to enact the intended walking movements – without any therapeutic training. He also showed in 2012 that paralyzed rats could recover after spinal cord injury after a few weeks of rehabilitation, combining electro-chemical stimulation and physiotherapy that uses a robotic harness.
At this year’s edition of South by South West (SXSW), Courtine describes this research in detail and his roadmap to transforming this technology into therapy for people suffering from paralysis. In particular, clinical trials are currently underway to test the feasibility of the spine-part of the brain-spine interface on patients with partial paralysis, in a collaboration with neurosurgeon Jocelyne Bloch at the Lausanne University Hospital (CHUV).
“This is the culmination of years of work,” says Courtine about the current clinical trials. “The results are so far promising, but the final outcomes must be carefully analyzed and no conclusions can be made yet.”
His approach to paralysis research is highly unconventional. Instead of focusing his energy on generating neural regrowth across spinal cord lesions that lead to paralysis, his approach relies on the plasticity of the nervous system, this incredible ability of the nervous system to adapt to damage. Based on his research, he is driven by the conviction that his neurorehabilitation protocol (electro-chemical stimulation and physiotherapy) drives the nervous system to reestablish connections across the lesion.
Elastic electrodes interfacing the body
At the interface of these innovative neuroprosthetic protocols are implantable electrodes that can read neural activity, stimulate nerves, and bypass nerve injury to reactivate biological function. Electrodes are surgically implanted into or on top of target nerve fibres, ready to sense electrical signals from neural activity or to deliver electric current that mimics the language of the nervous system.
There is a caveat. Conventional electrodes are rigid. Implanted in the human body, they aggravate surrounding tissue, leading to inflammation and tissue build-up that precipitate electrode dysfunction and necessite surgical removal.
But Lacour, who holds the Bertarelli Chair in Neuroprosthetic Technology, may have a solution. At SXSW, she presents flexible and stretchable electrodes that conform to the dynamics of the body in the hopes that these new electrodes will provoke less inflammation in the body, leading to longer-lasting – and more wearable – interfaces.
Her e-Dura implant is designed specifically for implantation on the surface of the brain or spinal cord. The small device closely imitates the mechanical properties of living tissue, and can simultaneously deliver electric impulses and pharmacological substances. The risks of rejection and/or damage to the spinal cord have been drastically reduced. Results so far in rodents have been encouraging.
“These electrodes are not yet clinically available,” warns Lacour. “Nevertheless, what we are learning can already be applied in a clinical context with my colleague Grégoire.”
Suggested Items
Real Time with... IPC APEX EXPO 2024: AI Implementation at Omron
04/18/2024 | Real Time with...IPC APEX EXPOEditor Nolan Johnson and Omron Product Manager Nick Fieldhouse discuss the company's focus on AI implementation to enhance customer experience and results. They address programming challenges and how AI can help customers achieve better outcomes with less experience. Omron's AI is compatible with existing systems, facilitating easy upgrades.
Cadence Unveils Palladium Z3 and Protium X3 Systems
04/18/2024 | Cadence Design SystemsThe Palladium Z3 and Protium X3 systems offer increased capacity, and scale from job sizes of 16 million gates up to 48 billion gates, so the largest SoCs can be tested as a whole rather than just partial models, ensuring proper functionality and performance.
Real Time with... IPC APEX EXPO 2024: MYCRONIC's Evolution and New Solutions
04/17/2024 | Real Time with...IPC APEX EXPOHenry Crandall interviews Kevin Clue, the vice president of global sales for MYCRONIC's High Flex division. They discuss the company's evolution, emphasizing its strong customer relationships and its role as a versatile, turnkey solution provider. Kevin unveils new solutions launched at IPC APEX EXPO, including an AI-integrated inspection system and the A40 pick-and-place platform. The conversation also touches on the increased use of AI and deep learning.
Australian Flow Batteries and The SCHMID Group Announce Groundbreaking Memorandum of Understanding
04/17/2024 | SCHMID GroupAustralian Flow Batteries Pty Ltd (AFB), a leader in innovative energy solutions and economical, safe, and reliable power storage, and SCHMID Energy Systems GmbH a company of the German SCHMID Group, a global technology leader with a rich history in delivering innovative solutions across multiple industries including Electronics, Renewables, and Energy Storage sectors, are thrilled to announce the signing of a Memorandum of Understanding (MoU)
Ansys Joins BAE Systems’ Mission Advantage Program to Advance Digital Engineering Across US Department of Defense
04/16/2024 | ANSYSAnsys announced it is working with BAE Systems, Inc., to accelerate the adoption of digital engineering and MBSE across the Department of Defense (DoD).